Healthpeak Properties, Inc. $DOC Shares Acquired by KBC Group NV

KBC Group NV lifted its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 23.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 128,403 shares of the real estate investment trust’s stock after buying an additional 24,426 shares during the period. KBC Group NV’s holdings in Healthpeak Properties were worth $2,110,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DOC. Advocate Investing Services LLC acquired a new position in Healthpeak Properties in the fourth quarter valued at $26,000. WPG Advisers LLC increased its position in shares of Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after purchasing an additional 1,197 shares in the last quarter. CYBER HORNET ETFs LLC acquired a new stake in shares of Healthpeak Properties during the second quarter worth about $33,000. Clearstead Advisors LLC lifted its holdings in shares of Healthpeak Properties by 166.3% in the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after purchasing an additional 1,216 shares during the last quarter. Finally, Elyxium Wealth LLC purchased a new stake in shares of Healthpeak Properties in the 4th quarter valued at about $31,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. This represents a 59.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.23% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Scotiabank raised their price target on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a research note on Wednesday, May 27th. JPMorgan Chase & Co. increased their price objective on Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a report on Wednesday, June 24th. Royal Bank Of Canada raised their target price on shares of Healthpeak Properties from $20.00 to $21.00 and gave the stock an “outperform” rating in a research report on Thursday, May 14th. Citigroup lifted their target price on shares of Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Finally, Weiss Ratings upgraded shares of Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Four equities research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $20.62.

Healthpeak Properties Stock Up 1.0%

DOC stock opened at $22.29 on Friday. Healthpeak Properties, Inc. has a one year low of $15.70 and a one year high of $22.77. The stock has a market capitalization of $15.37 billion, a PE ratio of 69.67, a price-to-earnings-growth ratio of 3.43 and a beta of 1.02. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The company has a fifty day moving average of $20.74 and a 200-day moving average of $18.45.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The business had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The business’s revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, analysts expect that Healthpeak Properties, Inc. will post 1.75 EPS for the current year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be issued a $0.1017 dividend. This represents a c) dividend on an annualized basis and a yield of 5.5%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s payout ratio is currently 381.25%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.